Endothelin-1 enhances glutamate-induced retinal cell death, possibly through ETA receptors

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 12, 2005, Pages 4684-4690

  Kobayashi, Takatoshi ^a   Oku, Hidehiro ^a   Fukuhara, Masayuki ^a   Kojima, Shota ^a   Komori, Asako ^a   Ichikawa, Masaki ^b   Katsumura, Kozo ^a   Kobayashi, Masato ^a   Sugiyama, Tetsuya ^a   Ikeda, Tsunehiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; GLUTAMIC ACID; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; TRYPAN BLUE; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FETUS; HYPOXIA; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA AMACRINE CELL; RETINA NERVE CELL; ANIMAL; CELL CULTURE; CELL DEATH; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; PREGNANCY; RETINA; WISTAR RAT;

AMACRINE CELLS; ANIMALS; CELL DEATH; CELLS, CULTURED; DRUG SYNERGISM; ENDOTHELIN-1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTAMIC ACID; IN SITU NICK-END LABELING; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; PREGNANCY; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RETINA; TRYPAN BLUE;

EID: 33644787646     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0785     Document Type: Article

References (46)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. MacCumber MW, Jampel HD, Snyder SH. Ocular effects of the endothelins: abundant peptides in the eye. Arch Ophthalmol. 1991;107:707-709.
3. de Juan JA, Moya FJ, Fernandez-Cruz A, Fernandez-Durango R. Identification of endothelin receptor subtypes in rat retina using subtype-selective ligands. Brain Res. 1995;690:25-33.
4. MacCumber MW, D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol. 1994;112:1231-1235.
5. Ripodas A, de Juan JA, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137-143.
6. Kiel JW. Endothelin modulation of choroidal blood flow in the rabbit. Exp Eye Res. 2000;71:543-550.
7. Koyama Y, Ishibashi T, Hayata K, Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res. 1993;600:81-88.
8. Koyama Y, Tsujikawa K, Matsuda T, Baba A. Endothelin-1 stimulates glial cell line-derived neurotrophic factor expression in cultured rat astrocytes. Biochem Biophys Res Commun. 2003;303:1101-1105.
9. Stanimirovic DB, Ball R, Mealing G, Morley P, Durkin JP. The role of intracellular calcium and protein kinase C in endothelin-stimulated proliferation of rat type I astrocytes. Glia. 1995;15:119-130.
10. Blomstrand F, Giaume C, Hansson E, Ronnback L. Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling. Am J Physiol. 1999;277:C616-C627.
11. Blomstrand F, Venance L, Siren AL, et al. Endothelins regulate astrocyte gap junctions in rat hippocampal slices. Eur J Neurosci. 2004;19:1005-1015.
12. Yagami T, Ueda K, Asakura K, et al. Effects of endothelin B receptor agonists on amyloid beta protein (25-35)-induced neuronal cell death. Brain Res. 2002;948:72-81.
13. Siren AL, Lewczuk P, Hasselblatt M, et al. Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo. Brain Res. 2002;945:144-149.
14. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucomapathophysiology? J Glaucoma. 2002;11:259-270.
15. Goto W, Oku H, Okuno T, Sugiyama T, Ikeda T. Amelioration of endothelin-1-induced optic nerve head ischemia by topical bunazosin. Curr Eye Res. 2005;30:81-91.
16. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
17. Cioffi GA, Wang L, Fortune B, et al. Chronic ischemia induces regional axonal damage in experimental primate optic neuropathy. Arch Ophthalmol. 2004;122:1517-1525.
18. Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol. 1999;44(suppl 1):S74-S84.
19. Orgul S, Cioffi GA, Bacon DR, Van Buskirk EM. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135-138.
20. Orgul S, Cioffi GA, Wilson DJ, Bacon DR, Van Buskirk EM. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci. 1996;37:1860-1869.
21. Stokely ME, Brady ST, Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest Ophthalmol Vis Sci. 2002;43:3223-3230.
22. Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ, Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002;43:2704-2713.
23. Levy DI, Sucher NJ, Lipton SA. Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons. Neurosci Lett. 1990;110:291-296.
24. el-Asrar AM, Morse PH, Maimone D, Torczynski E, Reder AT. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest Ophthalmol Vis Sci. 1992;33:3463-3468.
25. Kitano S, Morgan J, Caprioli J. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells. Exp Eye Res. 1996;63:105-112.
26. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483-3493.
27. Shihara M, Hirooka Y, Hori N, et al. Endothelin-1 increases the neuronal activity and augments the responses to glutamate in the NTS. Am J Physiol. 1998;275:R658-R665.
28. Kashii S, Takahashi M, Mandai M, et al. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest Ophthalmol Vis Sci. 1994;35:685-695.
29. Inoue A, Obata K, Akagawa K. Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1. J Biol Chem. 1992;267:10613-10619.
30. Inoue A, Akagawa K. Neuron specific expression of a membrane protein, HPC-1: tissue distribution, and cellular and subcellular localization of immunoreactivity and mRNA. Brain Res Mol Brain Res. 1993;19:121-128.
31. Hahn JS, Aizenman E, Lipton SA. Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Proc Natl Acad Sci USA. 1988;85:6556-6560.
32. Zhou QL, Strichartz G, Davar G. Endothelin-1 activates ET(A) receptors to increase intracellular calcium in model sensory neurons. Neuroreport. 2001;12:3853-3857.
33. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol. 1999;26:74-84.
34. Kakinuma Y, Miyauchi T, Yuki K, et al. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism. Circulation. 2001;103:2387-2394.
35. Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem. 2000;208:53-62.
36. Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. Molecular regulation of the endothelin-1 gene by hypoxia: contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem. 2001;276:12645-12653.
37. Desai D, He S, Yorio T, Krishnamoorthy RR, Prasanna G. Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem Biophys Res Commun. 2004;318:642-648.
38. Kolb H. Amacrine cells of the mammalian retina: neurocircuitry and functional roles. Eye. 1997;11:904-923.
39. Bloomfield SA, Dacheux RF. Rod vision: pathways and processing in the mammalian retina. Prog Retin Eye Res. 2001;20:351-384.
40. Jones BW, Watt CB, Frederick JM, Baehr W, et al. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol. 2003;464:1-16.
41. Williams RR, Cusato K, Raven MA, Reese BE. Organization of the inner retina following early elimination of the retinal ganglion cell population: effects on cell numbers and stratification patterns. Vis Neurosci. 2001;18:233-244.
42. Yamada H, Kurokawa K. Histochemical studies on endothelin and the endothelin-A receptor in the hypothalamus. J Cardiovasc Pharmacol. 1998;31(suppl 1):S215-S218.
43. Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia. 1999;42:1228-1234.
44. Kowluru RA, Engerman RL, Case GL, Kern TS. Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int. 2001;38:385-390.
45. Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res. 2004;28:47-54.
46. Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004;21:609-614.